Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Asialoglycoprotein receptor targeted optical and magnetic resonance imaging and therapy of liver fibrosis using pullulan stabilized multi-functional iron oxide nanoprobe.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- معلومة اضافية
- المصدر:
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
- بيانات النشر:
Original Publication: London : Nature Publishing Group, copyright 2011-
- الموضوع:
- نبذة مختصرة :
Early diagnosis and therapy of liver fibrosis is of utmost importance, especially considering the increased incidence of alcoholic and non-alcoholic liver syndromes. In this work, a systematic study is reported to develop a dual function and biocompatible nanoprobe for liver specific diagnostic and therapeutic applications. A polysaccharide polymer, pullulan stabilized iron oxide nanoparticle (P-SPIONs) enabled high liver specificity via asialogycoprotein receptor mediation. Longitudinal and transverse magnetic relaxation rates of 2.15 and 146.91 mM -1 s -1 respectively and a size of 12 nm, confirmed the T 2 weighted magnetic resonance imaging (MRI) efficacy of P-SPIONs. A current of 400A on 5 mg/ml of P-SPIONs raised the temperature above 50 °C, to facilitate effective hyperthermia. Finally, a NIR dye conjugation facilitated targeted dual imaging in liver fibrosis models, in vivo, with favourable histopathological results and recommends its use in early stage diagnosis using MRI and optical imaging, and subsequent therapy using hyperthermia.
(© 2021. The Author(s).)
- References:
Sci Rep. 2016 Oct 18;6:34976. (PMID: 27752038)
Contrast Media Mol Imaging. 2009 Jan-Feb;4(1):1-23. (PMID: 19156706)
Chemistry. 2020 Mar 2;26(13):2826-2836. (PMID: 31713928)
Sci Total Environ. 2011 Oct 15;409(22):4753-62. (PMID: 21851965)
Colloids Surf B Biointerfaces. 2015 Dec 1;136:1089-97. (PMID: 26595389)
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Aug 5;257:119741. (PMID: 33872953)
Biomaterials. 2014 Apr;35(12):3873-84. (PMID: 24485791)
J Cereb Blood Flow Metab. 2010 Jan;30(1):15-35. (PMID: 19756021)
Colloids Surf B Biointerfaces. 2014 May 1;117:216-24. (PMID: 24646453)
Sci Rep. 2018 Jul 20;8(1):10967. (PMID: 30030510)
Carbohydr Polym. 2014 Jan 30;101:760-8. (PMID: 24299836)
Colloids Surf B Biointerfaces. 2013 Jul 1;107:137-45. (PMID: 23475061)
Methods Mol Med. 2005;117:237-50. (PMID: 16118456)
Biomaterials. 2013 Sep;34(27):6328-38. (PMID: 23746856)
Biomaterials. 2013 Nov;34(33):8382-92. (PMID: 23932250)
Langmuir. 2012 Sep 11;28(36):13051-9. (PMID: 22889238)
Sci Rep. 2018 Jan 24;8(1):1531. (PMID: 29367754)
Phys Chem Chem Phys. 2015 Feb 14;17(6):4609-19. (PMID: 25586703)
Biomaterials. 2018 Jul;171:46-56. (PMID: 29680674)
Carbohydr Polym. 2012 Nov 6;90(4):1725-31. (PMID: 22944439)
Pharmacol Res. 2011 Oct;64(4):410-9. (PMID: 21723392)
Biomaterials. 2011 Mar;32(7):1890-905. (PMID: 21167595)
Nat Rev Gastroenterol Hepatol. 2010 Aug;7(8):425-36. (PMID: 20585339)
Eur J Pharm Sci. 2012 Jun 14;46(3):131-41. (PMID: 22369856)
Biomaterials. 2009 Aug;30(23-24):3926-33. (PMID: 19394687)
Toxicol In Vitro. 2007 Jun;21(4):545-57. (PMID: 17289342)
ACS Biomater Sci Eng. 2019 Jan 14;5(1):106-113. (PMID: 33405868)
Int J Pharm. 2000 May 15;201(1):59-69. (PMID: 10867265)
J Control Release. 2015 Apr 10;203:126-39. (PMID: 25701309)
Curr Drug Deliv. 2008 Oct;5(4):299-302. (PMID: 18855599)
Adv Healthc Mater. 2018 May;7(9):e1701201. (PMID: 29356419)
Sci Rep. 2014 Aug 06;4:5968. (PMID: 25095810)
Analyst. 2015 Jun 7;140(11):3773-80. (PMID: 25853289)
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. (PMID: 26742998)
AAPS J. 2013 Jul;15(3):696-706. (PMID: 23580183)
Biomaterials. 2013 Sep;34(29):7181-90. (PMID: 23791500)
Quant Imaging Med Surg. 2011 Dec;1(1):35-40. (PMID: 23256052)
ACS Nano. 2015 Jun 23;9(6):5825-32. (PMID: 25970038)
Acta Biomater. 2011 Jan;7(1):370-9. (PMID: 20659595)
J Magn Reson Imaging. 2007 Dec;26(6):1634-41. (PMID: 17968941)
Data Brief. 2018 Aug 31;20:1829-1835. (PMID: 30294631)
Stem Cell Res Ther. 2015 Mar 19;6:34. (PMID: 25889571)
Biomaterials. 2011 Aug;32(22):5187-94. (PMID: 21561660)
J Am Chem Soc. 2007 Mar 7;129(9):2628-35. (PMID: 17266310)
- الرقم المعرف:
0 (Asialoglycoprotein Receptor)
0 (Biocompatible Materials)
0 (Biomarkers)
0 (Ferric Compounds)
0 (Glucans)
0 (Magnetite Nanoparticles)
0 (Molecular Probes)
0 (Reactive Oxygen Species)
1K09F3G675 (ferric oxide)
8ZQ0AYU1TT (pullulan)
- الموضوع:
Date Created: 20210916 Date Completed: 20211210 Latest Revision: 20211214
- الموضوع:
20240628
- الرقم المعرف:
PMC8443657
- الرقم المعرف:
10.1038/s41598-021-97808-0
- الرقم المعرف:
34526590
No Comments.